APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valsartan Capsules Industry Growth and Trends Forecast to 2032

28 December 202590 pages

Choose your research edition.

Industry ResearchValsartan Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Capsules Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Valsartan Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Capsules Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Valsartan Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Capsules include Conquer, Dynemed, Mylan, Lepu Medical, Cisen Pharmaceutical, Torrent Pharmaceuticals, Teva Pharmaceutical Industries, Sun Pharmaceutical and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valsartan Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valsartan Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valsartan Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valsartan Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valsartan Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valsartan Capsules Market by Company

Conquer

Dynemed

Mylan

Lepu Medical

Cisen Pharmaceutical

Torrent Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical

Novartis

Valsartan Capsules Segment by Type

160 Mg

40 Mg

80 Mg

Others

Valsartan Capsules Segment by Application

Treatment of Hypertension

Treatment of Heart Disease

Others

Valsartan Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valsartan Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 160 Mg Table 2. Major Company of 40 Mg Table 3. Major Company of 80 Mg Table 4. Major Company of Others Table 5. Global Valsartan Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 7. Global Valsartan Capsules Sales Market Share in Volume by Type (2021-2026) Table 8. Global Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 9. Global Valsartan Capsules Sales Market Share in Value by Type (2021-2026) Table 10. Global Valsartan Capsules Price by Type (2021-2026) & (US$/Unit) Table 11. Global Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 12. Global Valsartan Capsules Sales Market Share in Volume by Type (2027-2032) Table 13. Global Valsartan Capsules Sales by Type (2027-2032) & (US$ Million) Table 14. Global Valsartan Capsules Sales Market Share in Value by Type (2027-2032) Table 15. Global Valsartan Capsules Price by Type (2027-2032) & (US$/Unit) Table 16. North America Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 17. North America Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 19. Europe Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 23. Latin America Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Valsartan Capsules Sales by Type (2021-2026) & (US$ Million) Table 26. Valsartan Capsules Industry Trends Table 27. Valsartan Capsules Industry Drivers Table 28. Valsartan Capsules Industry Opportunities and Challenges Table 29. Valsartan Capsules Industry Restraints Table 30. Global Valsartan Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Valsartan Capsules Revenue Market Share by Company (2021-2026) Table 32. Global Valsartan Capsules Sales by Company (2021-2026) & (K Units) Table 33. Global Valsartan Capsules Sales Share by Company (2021-2026) Table 34. Global Valsartan Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Valsartan Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Valsartan Capsules Major Company Production Sites and Headquarters Table 37. Global Valsartan Capsules Company, Product Type & Application Table 38. Global Valsartan Capsules Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Valsartan Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Valsartan Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Valsartan Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Valsartan Capsules Sales Market Share in Volume by Region (2021-2026) Table 44. Global Valsartan Capsules Sales by Region (2021-2026) & (US$ Million) Table 45. Global Valsartan Capsules Sales Market Share in Value by Region (2021-2026) Table 46. Global Valsartan Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Valsartan Capsules Sales by Region (2027-2032) & (K Units) Table 48. Global Valsartan Capsules Sales Market Share in Volume by Region (2027-2032) Table 49. Global Valsartan Capsules Sales by Region (2027-2032) & (US$ Million) Table 50. Global Valsartan Capsules Sales Market Share in Value by Region (2027-2032) Table 51. Global Valsartan Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Valsartan Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 54. Global Valsartan Capsules Sales Market Share in Volume by Application (2021-2026) Table 55. Global Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 56. Global Valsartan Capsules Sales Market Share in Value by Application (2021-2026) Table 57. Global Valsartan Capsules Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 59. Global Valsartan Capsules Sales Market Share in Volume by Application (2027-2032) Table 60. Global Valsartan Capsules Sales by Application (2027-2032) & (US$ Million) Table 61. Global Valsartan Capsules Sales Market Share in Value by Application (2027-2032) Table 62. Global Valsartan Capsules Price by Application (2027-2032) & (US$/Unit) Table 63. North America Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 64. North America Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 66. Europe Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 70. Latin America Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Valsartan Capsules Sales by Application (2021-2026) & (US$ Million) Table 73. Conquer Company Information Table 74. Conquer Business Overview Table 75. Conquer Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Conquer Valsartan Capsules Product Portfolio Table 77. Conquer Recent Development Table 78. Dynemed Company Information Table 79. Dynemed Business Overview Table 80. Dynemed Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Dynemed Valsartan Capsules Product Portfolio Table 82. Dynemed Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Valsartan Capsules Product Portfolio Table 87. Mylan Recent Development Table 88. Lepu Medical Company Information Table 89. Lepu Medical Business Overview Table 90. Lepu Medical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Lepu Medical Valsartan Capsules Product Portfolio Table 92. Lepu Medical Recent Development Table 93. Cisen Pharmaceutical Company Information Table 94. Cisen Pharmaceutical Business Overview Table 95. Cisen Pharmaceutical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cisen Pharmaceutical Valsartan Capsules Product Portfolio Table 97. Cisen Pharmaceutical Recent Development Table 98. Torrent Pharmaceuticals Company Information Table 99. Torrent Pharmaceuticals Business Overview Table 100. Torrent Pharmaceuticals Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Torrent Pharmaceuticals Valsartan Capsules Product Portfolio Table 102. Torrent Pharmaceuticals Recent Development Table 103. Teva Pharmaceutical Industries Company Information Table 104. Teva Pharmaceutical Industries Business Overview Table 105. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio Table 107. Teva Pharmaceutical Industries Recent Development Table 108. Sun Pharmaceutical Company Information Table 109. Sun Pharmaceutical Business Overview Table 110. Sun Pharmaceutical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sun Pharmaceutical Valsartan Capsules Product Portfolio Table 112. Sun Pharmaceutical Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Novartis Valsartan Capsules Product Portfolio Table 117. Novartis Recent Development Table 118. North America Valsartan Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 120. North America Valsartan Capsules Sales Market Share by Country (2021-2026) Table 121. North America Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Valsartan Capsules Sales Market Share Forecast by Country (2027-2032) Table 123. North America Valsartan Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Valsartan Capsules Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Valsartan Capsules Market Share by Country (2021-2026) Table 126. North America Valsartan Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Valsartan Capsules Market Share Forecast by Country (2027-2032) Table 128. Europe Valsartan Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 130. Europe Valsartan Capsules Sales Market Share by Country (2021-2026) Table 131. Europe Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Valsartan Capsules Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Valsartan Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Valsartan Capsules Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Valsartan Capsules Market Share by Country (2021-2026) Table 136. Europe Valsartan Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Valsartan Capsules Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Valsartan Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Valsartan Capsules Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Valsartan Capsules Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Valsartan Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Valsartan Capsules Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Valsartan Capsules Market Share by Country (2021-2026) Table 146. Asia-Pacific Valsartan Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Valsartan Capsules Market Share Forecast by Country (2027-2032) Table 148. Latin America Valsartan Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 150. Latin America Valsartan Capsules Sales Market Share by Country (2021-2026) Table 151. Latin America Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Valsartan Capsules Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Valsartan Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Valsartan Capsules Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Valsartan Capsules Market Share by Country (2021-2026) Table 156. Latin America Valsartan Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Valsartan Capsules Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Valsartan Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Valsartan Capsules Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Valsartan Capsules Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Valsartan Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Valsartan Capsules Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Valsartan Capsules Market Share by Country (2021-2026) Table 166. Middle East and Africa Valsartan Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Valsartan Capsules Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Valsartan Capsules Distributors List Table 171. Valsartan Capsules Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Valsartan Capsules Image Figure 2. Global Valsartan Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Capsules Sales (2021-2032) & (K Units) Figure 5. 160 Mg Image Figure 6. Global 160 Mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 40 Mg Image Figure 8. Global 40 Mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 80 Mg Image Figure 10. Global 80 Mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Valsartan Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Valsartan Capsules Market Share by Type 2025 VS 2032 Figure 15. North America Valsartan Capsules Sales Market Share in Volume by Type in 2025 Figure 16. North America Valsartan Capsules Sales Market Share in Value by Type in 2025 Figure 17. Europe Valsartan Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Europe Valsartan Capsules Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Valsartan Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Valsartan Capsules Sales Market Share in Value by Type in 2025 Figure 21. Latin America Valsartan Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Valsartan Capsules Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Valsartan Capsules Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Valsartan Capsules Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Valsartan Capsules Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Treatment of Hypertension Image Figure 28. Global Treatment of Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 29. Treatment of Heart Disease Image Figure 30. Global Treatment of Heart Disease Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Valsartan Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Valsartan Capsules Market Share by Application 2025 VS 2032 Figure 35. North America Valsartan Capsules Sales Market Share in Volume by Application in 2025 Figure 36. North America Valsartan Capsules Sales Market Share in Value by Application in 2025 Figure 37. Europe Valsartan Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Europe Valsartan Capsules Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Valsartan Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Valsartan Capsules Sales Market Share in Value by Application in 2025 Figure 41. Latin America Valsartan Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Valsartan Capsules Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Valsartan Capsules Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Valsartan Capsules Sales Market Share in Value by Application in 2025 Figure 45. North America Valsartan Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Valsartan Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Valsartan Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Valsartan Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valsartan Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Valsartan Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Valsartan Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Valsartan Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valsartan Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Valsartan Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Valsartan Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Valsartan Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valsartan Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Valsartan Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Valsartan Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Valsartan Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valsartan Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Valsartan Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Valsartan Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Valsartan Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Valsartan Capsules Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Valsartan Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 160 Mg
  • 40 Mg
  • 80 Mg
  • Others
Applications
  • Treatment of Hypertension
  • Treatment of Heart Disease
  • Others
Companies covered
  • Conquer
  • Dynemed
  • Mylan
  • Lepu Medical
  • Cisen Pharmaceutical
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valsartan Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valsartan Capsules Market by Type
  6. 1.3.1 160 Mg
  7. 1.3.2 40 Mg
  8. 1.3.3 80 Mg
  9. 1.3.4 Others
  10. 1.4 Global Valsartan Capsules Market Size by Type
  11. 1.4.1 Global Valsartan Capsules Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Valsartan Capsules Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Valsartan Capsules Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Valsartan Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Valsartan Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Valsartan Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Valsartan Capsules Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Valsartan Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valsartan Capsules Industry Trends
  2. 2.2 Valsartan Capsules Industry Drivers
  3. 2.3 Valsartan Capsules Industry Opportunities and Challenges
  4. 2.4 Valsartan Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valsartan Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Valsartan Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Valsartan Capsules Price (2021-2026)
  4. 3.4 Global Valsartan Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Valsartan Capsules Company, Product Type & Application
  7. 3.7 Global Valsartan Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Capsules Tier 1, Tier 2, and Tier 3
4 Valsartan Capsules Regional Status and Outlook
  1. 4.1 Global Valsartan Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valsartan Capsules Historic Market Size by Region
  3. 4.2.1 Global Valsartan Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valsartan Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valsartan Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valsartan Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Valsartan Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valsartan Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valsartan Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valsartan Capsules by Application
  1. 5.1 Valsartan Capsules Market by Application
  2. 5.1.1 Treatment of Hypertension
  3. 5.1.2 Treatment of Heart Disease
  4. 5.1.3 Others
  5. 5.2 Global Valsartan Capsules Market Size by Application
  6. 5.2.1 Global Valsartan Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Valsartan Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Valsartan Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Valsartan Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Valsartan Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Valsartan Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Valsartan Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Valsartan Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Conquer
  2. 6.1.1 Conquer Company Information
  3. 6.1.2 Conquer Business Overview
  4. 6.1.3 Conquer Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Conquer Valsartan Capsules Product Portfolio
  6. 6.1.5 Conquer Recent Developments
  7. 6.2 Dynemed
  8. 6.2.1 Dynemed Company Information
  9. 6.2.2 Dynemed Business Overview
  10. 6.2.3 Dynemed Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dynemed Valsartan Capsules Product Portfolio
  12. 6.2.5 Dynemed Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Valsartan Capsules Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Lepu Medical
  20. 6.4.1 Lepu Medical Company Information
  21. 6.4.2 Lepu Medical Business Overview
  22. 6.4.3 Lepu Medical Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lepu Medical Valsartan Capsules Product Portfolio
  24. 6.4.5 Lepu Medical Recent Developments
  25. 6.5 Cisen Pharmaceutical
  26. 6.5.1 Cisen Pharmaceutical Company Information
  27. 6.5.2 Cisen Pharmaceutical Business Overview
  28. 6.5.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
  30. 6.5.5 Cisen Pharmaceutical Recent Developments
  31. 6.6 Torrent Pharmaceuticals
  32. 6.6.1 Torrent Pharmaceuticals Company Information
  33. 6.6.2 Torrent Pharmaceuticals Business Overview
  34. 6.6.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
  36. 6.6.5 Torrent Pharmaceuticals Recent Developments
  37. 6.7 Teva Pharmaceutical Industries
  38. 6.7.1 Teva Pharmaceutical Industries Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Valsartan Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Valsartan Capsules Product Portfolio
  54. 6.9.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Valsartan Capsules Sales by Country
  2. 7.1.1 North America Valsartan Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valsartan Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Valsartan Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valsartan Capsules Market Size by Country
  6. 7.2.1 North America Valsartan Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valsartan Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Valsartan Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valsartan Capsules Sales by Country
  2. 8.1.1 Europe Valsartan Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valsartan Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Valsartan Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valsartan Capsules Market Size by Country
  6. 8.2.1 Europe Valsartan Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valsartan Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valsartan Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valsartan Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Valsartan Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valsartan Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valsartan Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valsartan Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Valsartan Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valsartan Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valsartan Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valsartan Capsules Sales by Country
  2. 10.1.1 South America Valsartan Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valsartan Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Valsartan Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valsartan Capsules Market Size by Country
  6. 10.2.1 South America Valsartan Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valsartan Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Valsartan Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valsartan Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Valsartan Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valsartan Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valsartan Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valsartan Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Valsartan Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valsartan Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valsartan Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valsartan Capsules Value Chain Analysis
  2. 12.1.1 Valsartan Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valsartan Capsules Production Mode & Process
  7. 12.2 Valsartan Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valsartan Capsules Distributors
  10. 12.2.3 Valsartan Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst